Reply: Cognitive behavioural therapy sessions approach ineffective for anxiety and depression in COPD: is the door closed for good?
- PMID: 38176703
- PMCID: PMC10764980
- DOI: 10.1183/13993003.02149-2023
Reply: Cognitive behavioural therapy sessions approach ineffective for anxiety and depression in COPD: is the door closed for good?
Abstract
Our trial does not support using a CBA approach to alleviate mild/moderate anxiety and/or depression in people with moderate/severe COPD. New approaches are needed to relieve the substantial mental health burden in these patients with complex needs.
Conflict of interest statement
Conflict of interest: L. Steed reports support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02), and also reports lecture honoraria from the IPCRG, outside the submitted work. K. Marshall reports support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02), and also reports lecture honoraria, outside the submitted work. M. Underwood is chief investigator or co-investigator on previous and current research grants from the UK NIHR, Arthritis Research UK and on grants funded by the Australian NHMRC and Norwegian MRC; he was an NIHR Senior Investigator until March 2021; he has received travel expenses for speaking at conferences from the professional organisations hosting the conferences; he is a director and shareholder of Clinvivo Ltd; he is part of an academic partnership with Serco Ltd, funded by the European Social Fund; he is a co-investigator in studies that are, or have had, additional support from Stryker Ltd; and until March 2020 he received a fee as an NIHR journal editor and editors group member. P. White is a chief investigator or co-investigator on multiple previous and current research grants from the NIHR, and reports travel expenses for speaking at conferences from the professional organisations hosting the conferences. H. Pinnock reports support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02), and also reports lecture honoraria from Sandoz, Teva and Boehringer Ingelheim, outside the submitted work. S.J.C. Taylor, M.J. Kelly and R. Sohanpal report support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02).
Comment on
-
Tailored psychological intervention for anxiety or depression in COPD (TANDEM): a randomised controlled trial.Eur Respir J. 2023 Nov 2;62(5):2300432. doi: 10.1183/13993003.00432-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37620042 Free PMC article. Clinical Trial.
References
-
- Clark DM. IAPT at 10: Achievements and Challenges. Date last updated: 13 February 2019. Date last accessed: 25 November 2023. www.england.nhs.uk/blog/iapt-at-10-achievements-and-challenges/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical